CA2171369A1 - Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccins - Google Patents
Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccinsInfo
- Publication number
- CA2171369A1 CA2171369A1 CA002171369A CA2171369A CA2171369A1 CA 2171369 A1 CA2171369 A1 CA 2171369A1 CA 002171369 A CA002171369 A CA 002171369A CA 2171369 A CA2171369 A CA 2171369A CA 2171369 A1 CA2171369 A1 CA 2171369A1
- Authority
- CA
- Canada
- Prior art keywords
- liposomes
- virulence factors
- vaccines
- pathogens
- antibiotics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000304 virulence factor Substances 0.000 title abstract 2
- 230000007923 virulence factor Effects 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000002502 liposome Substances 0.000 abstract 6
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 230000002458 infectious effect Effects 0.000 abstract 2
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000001539 phagocyte Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002171369A CA2171369C (fr) | 1996-03-08 | 1996-03-08 | Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccins |
| US09/251,304 US6221386B1 (en) | 1996-03-08 | 1999-02-17 | Use of virulence factors of pathogens to improve liposomal delivery of therapeutic agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002171369A CA2171369C (fr) | 1996-03-08 | 1996-03-08 | Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2171369A1 true CA2171369A1 (fr) | 1997-09-09 |
| CA2171369C CA2171369C (fr) | 2008-09-09 |
Family
ID=4157717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002171369A Expired - Fee Related CA2171369C (fr) | 1996-03-08 | 1996-03-08 | Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccins |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2171369C (fr) |
-
1996
- 1996-03-08 CA CA002171369A patent/CA2171369C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2171369C (fr) | 2008-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69839699D1 (de) | Vaginales lactobacillus-medikament | |
| CA2253837A1 (fr) | Applications therapeutiques de produits proteiques bactericides/augmentant la permeabilite (bpi) dans le cas de meningococcemies chez l'homme | |
| EP1283050A3 (fr) | Compositions thérapeutiques améliorées comprenant des protéines augmentant le pouvoir bactéricide perméabilisant | |
| CA2223505A1 (fr) | Peptides a base d'histatine a activite antifongique et antibacterienne | |
| HUT76258A (en) | Compositions comprising dna damaging agents and p53, and methods for uses thereof | |
| MX9406552A (es) | Metodo, composiciones y dispositivos para la admi nistracion de polinucleotidos desnudos que codifi can peptidos biologicamente activos. | |
| CO4290346A1 (es) | Formas de dosificacion de liberacion controlada de azitromicina | |
| CA2172245A1 (fr) | Methode pour traiter l'infection bacterienne gram-negative par administration de proteines bactericides/augmentant la permeabilite (bpi) | |
| ES2196092T3 (es) | Composicion antibacteriana liposomica, de baja rigidez. | |
| NZ510690A (en) | Methods for administration of antibiotics | |
| IL141639A (en) | Multicomponent vaccines | |
| AU6549898A (en) | Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina | |
| IL110045A0 (en) | Pharmaceutical compositions containing oligopeptides combating aids and arc and for immune stimulation and certain such novel oligopeptides | |
| WO1997018790A3 (fr) | Agents therapeutiques et de diagnostic pour traiter les infections microbiennes | |
| AU2000255628A1 (en) | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections | |
| AU7242796A (en) | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis | |
| CA2255539A1 (fr) | Utilisations therapeutiques de produits proteiques bpi chez des patients humains souffrant d'une hemorragie causee par un traumatisme | |
| WO2000000214A3 (fr) | Preparations pharmaceutiques destinees a combattre ou a prevenir les infections superficielles provoquees par des micro-organismes | |
| WO1994008613A3 (fr) | Utilisation de parathormone, de ses fragments a activite biologique et de peptides associes pour le traitement de problemes de grossesse | |
| WO1997005899A3 (fr) | Nouveaux vaccins et nouvelles compositions pharmaceutiques utilisant des vesicules de membrane de micro-organismes et leurs procedes d'elaboration | |
| WO2000030435A3 (fr) | Traitement contre la loque | |
| WO2003009859A1 (fr) | Immunotherapie pour humains | |
| CA2420640A1 (fr) | Preparations combinees de derives d'acide 3-n-formyl- hydroxyamino-propylphosphonique ou de derives d'acide 3-n- acethyl-hydroxyamino-propylphosphonique avec ingredients speciaux pharmaceutiquement actifs | |
| CA2171369A1 (fr) | Utilisation d'aggressines d'agents pathogenes permettant d'ameliorer l'administration liposomique d'antibiotiques et (ou) de vaccins | |
| CA2074503A1 (fr) | Formulation pharmaceutique contenant du penciclovir |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |